Levels	O
of	O
expression	O
of	O
CYR61	O
and	O
CTGF	O
are	O
prognostic	O
for	O
tumor	B-Cancer
progression	O
and	O
survival	O
of	O
individuals	O
with	O
gliomas	B-Cancer
.	O

The	O
biological	O
properties	O
of	O
CCN	O
proteins	O
include	O
stimulation	O
of	O
cell	B-Cell
proliferation	O
,	O
migration	O
,	O
and	O
adhesion	O
,	O
as	O
well	O
as	O
angiogenesis	O
and	O
tumorigenesis	O
.	O

We	O
quantified	O
CYR61	O
,	O
CTGF	O
,	O
WISP	O
-	O
1	O
,	O
and	O
NOV	O
mRNA	O
expression	O
levels	O
in	O
samples	B-Cancer
from	O
sixty	O
-	O
six	O
primary	B-Cancer
gliomas	I-Cancer
and	O
five	O
normal	O
brain	B-Multi-tissue_structure
samples	I-Multi-tissue_structure
using	O
quantitative	O
real	O
-	O
time	O
PCR	O
assay	O
.	O

Statistical	O
analysis	O
was	O
performed	O
to	O
explore	O
the	O
links	O
between	O
expression	O
of	O
the	O
CCN	O
genes	O
and	O
clinical	O
and	O
pathological	O
parameters	O
.	O

Overexpression	O
of	O
CYR61	O
,	O
CTGF	O
,	O
WISP	O
-	O
1	O
,	O
and	O
NOV	O
occurred	O
in	O
48	O
%	O
(	O
32	O
of	O
66	O
)	O
,	O
58	O
%	O
(	O
38	O
of	O
66	O
)	O
,	O
36	O
%	O
(	O
24	O
of	O
66	O
)	O
,	O
and	O
15	O
%	O
(	O
10	O
of	O
66	O
)	O
of	O
primary	B-Cancer
gliomas	I-Cancer
,	O
respectively	O
.	O

Interestingly	O
,	O
significant	O
associations	O
were	O
found	O
between	O
CYR61	O
expression	O
versus	O
tumor	B-Cancer
grade	O
,	O
pathology	O
,	O
gender	O
,	O
and	O
age	O
at	O
diagnosis	O
.	O

Also	O
,	O
a	O
significant	O
correlation	O
existed	O
between	O
CTGF	O
mRNA	O
levels	O
versus	O
tumor	B-Cancer
grade	O
,	O
gender	O
,	O
and	O
pathology	O
.	O

In	O
contrast	O
to	O
CYR61	O
and	O
CTGF	O
,	O
no	O
significant	O
association	O
was	O
found	O
between	O
expression	O
of	O
either	O
WISP	O
-	O
1	O
or	O
NOV	O
versus	O
any	O
of	O
the	O
pathological	O
features	O
.	O

Furthermore	O
,	O
Cox	O
regression	O
analysis	O
showed	O
that	O
CYR61	O
and	O
CTGF	O
expression	O
had	O
a	O
significant	O
correlation	O
with	O
patient	O
survival	O
.	O

These	O
results	O
suggest	O
that	O
CYR61	O
and	O
CTGF	O
may	O
play	O
a	O
role	O
in	O
the	O
progression	O
of	O
gliomas	B-Cancer
;	O
their	O
levels	O
at	O
diagnosis	O
may	O
have	O
prognostic	O
significance	O
;	O
and	O
these	O
proteins	O
might	O
serve	O
as	O
valuable	O
targets	O
for	O
therapeutic	O
intervention	O
.	O

